Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Aoshima (Kamogawa, Japan). Effectiveness of the 23-valent pneumococcal polysaccharide vaccine for the patients with lung comorbidities; a single center, retrospective, self-controlled case series study. 4515

Member's Comments

No comment yet.

Related content which might interest you: A randomized, open-label, parallel design study to compare the immunogenicity of simultaneous administration versus sequential administration of quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in the elderly Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Effectiveness of the pneumococcal vaccine in older adults living in the community: a prospective cohort study Source: Eur Respir J 2005; 26: Suppl. 49, 143s Year: 2005 A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany Source: Eur Respir J, 59 (2) 2102432; 10.1183/13993003.02432-2021 Year: 2022 Clinical presentations and serotypes causing invasive pneumococcal disease in adults vaccinated with the 23-valent polysaccharide pneumococcal vaccine (PPV23) in Spain. The ODIN study (2010-2013) Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014 Clinical evolution of patients with COPD after administration of 23-valent pneumococcal capsular polysacharide vaccine (PCPV) Source: Eur Respir J 2005; 26: Suppl. 49, 286s Year: 2005 Clinical efficacy of pneumococcal vaccine in COPD patients. preliminary results Source: Eur Respir J 2003; 22: Suppl. 45, 408s Year: 2003 Pneumococcal vaccination in chronic respiratory patients – a cohort study Source: International Congress 2019 – Airway infection in COPD Year: 2019 Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects Source: Eur Respir J 2005; 26: 1086-1091 Year: 2005 Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area Source: Eur Respir J 2007; 30: 414-422 Year: 2007 The remaining challenges of pneumococcal disease in adults Source: Eur Respir Rev 2012; 21: 57-65 Year: 2012 Effectiveness of a 23-valent pneumococcal polysaccharide vaccine and a 13-valent pneumococcal conjugate vaccine among the elderly with chronic respiratory diseases Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 Effect of pneumococcal conjugate vaccination on radiological findings of chest in infants hospitalized with community acquired pneumonia in northern India: a case-control study Source: International Congress 2019 – Epidemiology of childhood respiratory diseases Year: 2019 No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area Source: ERS Live 2007 Year: 2007 Effectiveness data on prevention of COPD exacerbations with 13-valent pneumococal conjugate vaccine (PCV13) Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Efficacy of influenza and pneumococcal vaccinations among patients with COPD Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Clinical presentation and outcomes of pneumococcal pneumonia in adults. A comparative study between two consecutive years in a university hospital Source: Eur Respir J 2006; 28: Suppl. 50, 373s Year: 2006 Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Source: Eur Respir J 2004; 23: 363-368 Year: 2004 Assessment of medical undergraduates’ relation to pneumococcal conjugate vaccine use Source: Virtual Congress 2021 – Medical education in respiratory medicine Year: 2021 The extent of microbiological testing and antibiotic de-escalation in adults with community-acquired pneumonia: a retrospective cohort study. Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018